High prevalence of thromboembolic complications in heart transplant recipients: Which preventive strategy?

Transplantation

Volumn 61, Issue 5, 1996, Pages 757-762

  Forrat, Rémi ^a   Ferrera, René ^a   Boissonnat, Pascale ^a   Adeleine, Patrice ^b   Dureau, Georges ^c   Ninet, Jean ^c   De Lorgeril, Michel ^a  

^a CNRS   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; ANTITHROMBOCYTIC AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EMBOLISM; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STROKE; SUDDEN DEATH; THROMBOEMBOLISM; THROMBOPHLEBITIS; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 0029664391     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00015     Document Type: Article

References (31)

1. Vanrenterghem Y, Roels L, Lerut T, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; 4: 999.
2. Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. Transplantation 1991; 51: 406.
3. Taylor JE, Scott N, Hill A, et al. Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 1993; 55: 500.
4. de Lorgeril M, Dureau G, Boissonnat P, et al. Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients. Arterioscler Thromb 1992; 12: 222.
5. Hunt BJ, Segal H, Yacoub M. Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis. Transplantation 1993; 55: 309.
6. de Lorgeril M, Boissonnat P, Mamelle N, et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 1994; 89: 2590.
7. Olivari MT, Kubo SH, Braunlin EA, Bolman RM, Ring WS. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 1990; 82 (suppl IV): 276.
8. Uretsky BF, Kormos RL, Zerbe TR, et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant 1992; 11: S45.
9. Braunlin EA, Hunter DW, Canter CE, et al. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression. Circulation 1991; 84 (suppl III): 303.
10. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987; 4: 19.
11. de Lorgeril M, Loire R, Guidollet J, Boissonnat P, Dureau G, Renaud S. Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis. J Intern Med 1993; 233: 343.
12. de Lorgeril M, Dureau G, Boissonnat P, et al. Increased platelet aggregation after heart transplantation: influence of aspirin. J Heart Lung Transplant 1991; 10: 600.
13. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell JWG. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83: 38.
14. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454.
15. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billigham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Lung Transplant 1989; 8: 349.
16. Gao SZ, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 1989; 64: 1093.
17. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137.
18. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635.
19. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Eight-year results of cyclosporine-treated patients with cardiac transplants. J Thorac Cardiovasc Surg 1990; 99: 500.
20. Fragomeni LS, Kaye MP. The registry of the international society for heart transplantation: fifth official report. J Heart Transplant 1988; 7: 249.
21. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147.
22. ASPECT. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499.
23. Rao KV. Thromboembolic complications in 240 cadaver kidney transplant recipients treated with conventional immunosuppressive drugs. Lancet 1985; 14: 607.
24. Zazgornik J, Kopsa H, Balcke P, Minar E, Shaheen F. Venous thrombosis and cyclosporin. Lancet 1985; 13: 101.
25. Kronenberg F, Lhotta K, Joannidis M, Königsrainer A, Margreiter R, König P. Thromboembolic complications in renal allograft recipients: triple-drug therapy in comparison with cyclosporine A-prednisone. Clin Transplant 1993; 7: 339.
26. Bordet JC, de Lorgeril M, Durbin S, Boissonnat P, Renaud S, Dureau G. Evaluation of renal and systemic production of prostacyclin in cyclosporin-treated heart transplant recipients. Am J Cardiol 1993; 72: 486.
27. Chancerelle Y, de Lorgeril M, Viret R, et al. Increased lipid peroxidation in cyclosporin-treated heart transplant recipients. Am J Cardiol 1991; 68: 813.
28. de Lorgeril M, Richard MJ, Arnaud J, et al. Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis. Am Heart J 1993; 125: 974.
29. de Lorgeril M, Richard MJ, Arnaud J, et al. Increased production of reactive oxygen species in pharmacologically-immunosuppressed patients. Chem Biol Interact 1994; 91: 159.
30. de Lorgeril M, Boissonnat P, Salen P, et al. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporin treatment in heart transplant recipients. Transplantation 1994; 58: 193.
31. de Lorgeril M, Boissonnat P, Dureau G, Guidollet J, Renaud S. Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients. Transplantation 1993; 55: 1195.